MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multidisciplinary Approach"

  • 2023 International Congress

    A baseline study for the first year of a diverse Parkinson’s Disease interdisciplinary clinic

    V. Armengol, M. Sarno, M. Feldman, S. Marmol, A. Alfonso, G. Dumenigo, M. Garcia-Casals, S. Munzesheimer, A. Otto, TW. Siu, D. Shpiner (Miami, USA)

    Objective: To characterize patients at a new diverse, academic Parkinson’s Disease (PD) interdisciplinary clinic (IDC). Background: PD affects patients in nearly all spheres of life,…
  • 2023 International Congress

    Chinese medicine pattern diagnostic criteria in clinical and epidemiological studies of Parkinson’s disease: a systematic review

    CP. Ho, S. Yuen, C. Chan, M. Li, KK. Chua (Hong Kong, Hong Kong)

    Objective: To summarize the diagnostic criteria of Chinese medicine patterns (CMPs) adopted by clinical and epidemiological studies of Parkinson’s disease (PD). Background: One major reason…
  • 2022 International Congress

    The phenomenon of unexpectedly high functional mobility in people with typical Parkinson’s disease. A cross-sectional data analysis.

    A-M. Hanff, C. Mccrum, G. Aguayo, A. Rauschenberger, A. Leist, R. Krüger, M. Zeegers (Strassen, Luxembourg)

    Objective: To describe the frequency of people with typical Parkinson’s disease (PD) with unexpectedly high functional mobility (a high functional mobility despite the presence of…
  • 2022 International Congress

    Challenges in Outcome Measure Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease

    C. Gonzalez-Robles, M. Bartlett, M. Burnell, R. Chapman, R. Chaudhuri, C. Clarke, R. Ellis-Doyle, M. Hu, B. Huxford, A. Jha, M. Lawton, G. Mills, A. Noyce, P. Piccini, L. Rochester, J. Rudiger, C. Siu, D. van Wamelen, C. Williams-Gray, ML. Zeissler, H. Zetterberg, C. Carroll, T. Foltynie, R. Weil, A. Schrag (London, United Kingdom)

    Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson Disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatment for…
  • 2022 International Congress

    Clinical Manifestations of Metabolic Syndrome in Parkinson’s Disease – Report from Indonesia Tertiary Referral Hospital

    DA. Soraya, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: The study aims to determine the prevalence of metabolic syndrome and related factors in Parkinson's disease (PD). Background: Parkinson's disease is a neurodegenerative disorder,…
  • 2022 International Congress

    Involving people with lived experience of Parkinson’s in trial design: the EJS ACT-PD initiative

    M-L. Zeissler, N. Bakshi, M. Bartlett, A. Batla, D. Byrom, R. Chapman, E. Deeson, R. Ellis-Doyle, C. Gonzales-Robles, A. Jewell, H. Matthews, L. Miller, G. Mills, L. Mooney, A. Morgan, J. Rudiger, D. Salathiel, P. Scurfield, C. Siu, S. Whipps, S. Wonnacott, T. Foltynie, C. Carroll, K. Mcfarthing (Plymouth, United Kingdom)

    Objective: To maximally involve people with the lived experience of Parkinson’s in the design of the first multi-arm multi-stage (MAMS) trial for disease modifying therapies…
  • 2022 International Congress

    Feasibility of using wearable sensors to monitor activity and sleep patterns in inpatients with delirium and Parkinson’s disease

    G. Bate, S. Richardson, JP. Taylor, D. Burn, L. Allan, A. Yarnall, Y. Guan, S. Del-Din, R. Lawson (Newcastle-Upon-Tyne, United Kingdom)

    Objective: To assess the feasibility of using wearable sensors in Parkinson's disease (PD) inpatients with/without delirium and to quantify clinically relevant digital outcomes to facilitate…
  • 2022 International Congress

    International Telemedicine during COVID-19 Pandemic in an Academic Movement Disorder Clinic

    N. Beltre, I. Haq, C. Luca, J. Margolesky, H. Paul, C. Singer, D. Shpiner (Miami, USA)

    Objective: To assess international patients’ access to medical care from their movement disorder specialist before and during the COVID-19 pandemic and the impact of the…
  • 2022 International Congress

    Dysphagia management in Parkinson’s patients during admission to Royal Berkshire Hospital(RBH),Reading,UK.

    M. Khwaja, G. Desai, J. Murphy, A. Chatterjee (Reading, United Kingdom)

    Objective: To evaluate dysphagia management in Parkinson’s patients according to National Confidential Enquiry into Patient Outcome and Death(NCEPOD)report 2021 recommendations. Background: Dysphagia is inevitable in…
  • 2022 International Congress

    Advance Care Planning and Parkinson’s disease: patient knowledge assessment

    B. Rodrigues, E. Cournean, N. Prakash, D. Costello, K. Badiola, C. Selvadurai (Farmington, USA)

    Objective: Evaluate disease knowledge in patients with Parkinson’s disease in an Advance Care Planning (ACP) clinic. Background: Poor disease knowledge has been associated with misconceptions…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 25
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley